The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients
Authors
Keywords
Cancer stem cells, Oct4, c-Myc, Nanog, Ovarian cancer
Journal
CELLULAR ONCOLOGY
Volume 36, Issue 5, Pages 363-374
Publisher
Springer Nature
Online
2013-08-08
DOI
10.1007/s13402-013-0142-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eradicating cancer cells: struggle with a chameleon
- (2015) Jiabo Di et al. Oncotarget
- Oxidants, antioxidants and the current incurability of metastatic cancers
- (2013) J. Watson Open Biology
- Functional OCT4-specific CD4+and CD8+T cells in healthy controls and ovarian cancer patients
- (2013) Jiabo Di et al. OncoImmunology
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy
- (2012) James A. McCubrey et al. CURRENT PHARMACEUTICAL DESIGN
- Nanog signaling in cancer promotes stem-like phenotype and immune evasion
- (2012) Kyung Hee Noh et al. JOURNAL OF CLINICAL INVESTIGATION
- A Molecular Beacon-Based Method for Screening Cervical Cancer
- (2012) Suxia Han et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
- (2012) Vinod Vathipadiekal et al. PLoS One
- Intratumoral Heterogeneity in the Self-Renewal and Tumorigenic Differentiation of Ovarian Cancer
- (2012) Sagi Abelson et al. STEM CELLS
- Ovarian cancer stem cells and inflammation
- (2011) Gil Mor et al. CANCER BIOLOGY & THERAPY
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- Distinct Types of Tumor-Initiating Cells Form Human Colon Cancer Tumors and Metastases
- (2011) Sebastian M. Dieter et al. Cell Stem Cell
- Cytokine analysis as a tool to understand tumour–host interaction in ovarian cancer
- (2011) Refika Yigit et al. EUROPEAN JOURNAL OF CANCER
- Cancer Cells Cyclically Lose and Regain Drug-Resistant Highly Tumorigenic Features Characteristic of a Cancer Stem-like Phenotype
- (2011) K. He et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the Mitochondria Activates Two Independent Cell Death Pathways in Ovarian Cancer Stem Cells
- (2011) A. B. Alvero et al. MOLECULAR CANCER THERAPEUTICS
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
- (2011) Robert Strauss et al. PLoS One
- c-Myc Regulates Self-Renewal in Bronchoalveolar Stem Cells
- (2011) Jie Dong et al. PLoS One
- Long-Term Sphere Culture Cannot Maintain a High Ratio of Cancer Stem Cells: A Mathematical Model and Experiment
- (2011) Tang Peng et al. PLoS One
- Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
- (2011) J. M. Stewart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural Killer Cells Preferentially Target Cancer Stem Cells; Role of Monocytes in Protection Against NK Cell Mediated Lysis of Cancer Stem Cells
- (2011) Anahid Jewett et al. Current Drug Delivery
- Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
- (2010) Elsa Quintana et al. CANCER CELL
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- myc maintains embryonic stem cell pluripotency and self-renewal
- (2010) Natalia V. Varlakhanova et al. DIFFERENTIATION
- The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches
- (2010) Lara Lacerda et al. DRUG RESISTANCE UPDATES
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma
- (2010) Shidou Zhao et al. JOURNAL OF PATHOLOGY
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- Natural immunity to pluripotency antigen OCT4 in humans
- (2010) K. M. Dhodapkar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD133 antigen expression in ovarian cancer
- (2009) Gabriella Ferrandina et al. BMC CANCER
- Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research
- (2008) Stefanie Liedtke et al. BIOLOGICAL CHEMISTRY
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- IL-6-Induced Stimulation of c-Myc Translation in Multiple Myeloma Cells Is Mediated by Myc Internal Ribosome Entry Site Function and the RNA-Binding Protein, hnRNP A1
- (2008) Y. Shi et al. CANCER RESEARCH
- Requirement of Nanog dimerization for stem cell self-renewal and pluripotency
- (2008) J. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype
- (2008) Nicholas B Berry et al. Journal of Ovarian Research
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started